Aldesleukin

BreastfeedingPediatric
  • TRADE NAMES: Aerovent; Atem; Atronase; Narilet; Proleukin (Chiron)
  • INDICATIONS: Metastatic renal cell carcinoma and metastatic melanoma
  • SYNONYM: IL-2; interleukin-2
  • CLASS: Biologic, Immunomodulator, Interleukin-2
  • HALF-LIFE: 6–85 minutes

Contra-indicated in patients with significant cardiac, pulmonary, renal, hepatic, or CNS impairment.

CAPILLARY LEAK SYNDROME

See full prescribing information for complete boxed warning.

Our database has 121 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
RENAL
HEMATOLOGIC
OCULAR
LOCAL
OTHER


Page last updated 10/17/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric